243 related articles for article (PubMed ID: 26233500)
21. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
22. Anti-angiotensin II type 1 receptor autoantibodies (AT
İlgen U; Yayla ME; Düzgün N
Rheumatol Int; 2017 Apr; 37(4):593-598. PubMed ID: 28004166
[TBL] [Abstract][Full Text] [Related]
23. Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.
Cutolo M; Herrick AL; Distler O; Becker MO; Beltran E; Carpentier P; Ferri C; Inanç M; Vlachoyiannopoulos P; Chadha-Boreham H; Cottreel E; Pfister T; Rosenberg D; Torres JV; Smith V;
Arthritis Rheumatol; 2016 Oct; 68(10):2527-39. PubMed ID: 27111549
[TBL] [Abstract][Full Text] [Related]
24. Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.
Cabral-Marques O; Riemekasten G
Autoimmun Rev; 2016 Jul; 15(7):690-4. PubMed ID: 26970493
[TBL] [Abstract][Full Text] [Related]
25. Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis.
Friedrich S; Lüders S; Glimm AM; Werner SG; Schmittat G; Burmester GR; Backhaus M; Riemekasten G; Ohrndorf S
Arthritis Res Ther; 2019 Apr; 21(1):96. PubMed ID: 30987674
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort.
Allanore Y; Denton CP; Krieg T; Cornelisse P; Rosenberg D; Schwierin B; Matucci-Cerinic M;
Ann Rheum Dis; 2016 Sep; 75(9):1736-40. PubMed ID: 27353738
[No Abstract] [Full Text] [Related]
27. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.
Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528
[TBL] [Abstract][Full Text] [Related]
28. Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients.
Leroy V; Henrot P; Barnetche T; Cario M; Darrigade AS; Manicki P; Doutre MS; Lazaro E; Constans J; Barcat D; Vernhes JP; Richez C; Taieb A; Truchetet ME; Seneschal J;
J Am Acad Dermatol; 2019 Feb; 80(2):478-484. PubMed ID: 30092330
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study.
Caimmi C; Bertoldo E; Pozza A; Caramaschi P; Orsolini G; Gatti D; Rossini M; Viapiana O
Int J Rheum Dis; 2019 Jun; 22(6):1041-1045. PubMed ID: 30938067
[TBL] [Abstract][Full Text] [Related]
30. Agonistic antibodies in systemic sclerosis.
Moroncini G; Svegliati Baroni S; Gabrielli A
Immunol Lett; 2018 Mar; 195():83-87. PubMed ID: 29032187
[TBL] [Abstract][Full Text] [Related]
31. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
[TBL] [Abstract][Full Text] [Related]
32. A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis.
Chang SH; Jun JB; Lee YJ; Kang TY; Moon KW; Ju JH; Kang SW; Choi IA; Park YB; Lee SG; Lee SS; Heo NH; Lee EB
Rheumatology (Oxford); 2021 Dec; 60(12):5814-5819. PubMed ID: 33576774
[TBL] [Abstract][Full Text] [Related]
33. A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients.
Silva I; Almeida J; Vasconcelos C
Autoimmun Rev; 2015 Feb; 14(2):140-52. PubMed ID: 25449678
[TBL] [Abstract][Full Text] [Related]
34. Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study.
Frerix M; Stegbauer J; Dragun D; Kreuter A; Weiner SM
Rheumatology (Oxford); 2012 Apr; 51(4):735-42. PubMed ID: 22190687
[TBL] [Abstract][Full Text] [Related]
35. [Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].
Launay D; Diot E; Pasquier E; Mouthon L; Boullanger N; Fain O; Jego P; Carpentier P; Hatron PY; Hachulla E
Presse Med; 2006 Apr; 35(4 Pt 1):587-92. PubMed ID: 16614599
[TBL] [Abstract][Full Text] [Related]
36. Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).
Mecoli CA; Perin J; Van Eyk JE; Zhu J; Fu Q; Allmon AG; Rao Y; Zeger S; Wigley FM; Hummers LK; Shah AA
Clin Rheumatol; 2020 Apr; 39(4):1199-1205. PubMed ID: 31858338
[TBL] [Abstract][Full Text] [Related]
37. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
38. The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).
Pestaña-Fernández M; Rubio-Rivas M; Tolosa-Vilella C; Guillén-Del-Castillo A; Colunga-Argüelles D; Argibay A; Marí-Alfonso B; Marín-Ballvé A; Pla-Salas X; Chamorro AJ; Castro-Salomó A; Madroñero-Vuelta AB; Sánchez-García ME; Sáez-Comet L; González-Echávarri C; Ortego-Centeno N; Vargas-Hitos JA; Todolí-Parra JA; Trapiella-Martínez L; Lledó GM; Freire M; Fonollosa-Pla V; Simeón-Aznar CP;
Rheumatology (Oxford); 2021 Feb; 60(2):872-880. PubMed ID: 32844220
[TBL] [Abstract][Full Text] [Related]
39. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of data from a prospective cohort study.
Kim A; Kim Y; Kim GT; Ahn E; So MW; Sohn DH; Lee SG
Rheumatol Int; 2020 Jul; 40(7):1071-1079. PubMed ID: 32424613
[TBL] [Abstract][Full Text] [Related]
40. Digital ulcers in systemic sclerosis: role of flow-mediated dilatation and capillaroscopy as risk assessment tools.
Silva I; Loureiro T; Teixeira A; Almeida I; Mansilha A; Vasconcelos C; Almeida R
Eur J Dermatol; 2015; 25(5):444-51. PubMed ID: 26693634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
